$6.00
2.44% yesterday
Nasdaq, Jun 27, 10:00 pm CET
ISIN
CA74319B5027
Symbol
PROF

Profound Medical Corp Target price 2025 - Analyst rating & recommendation

Profound Medical Corp Classifications & Recommendation:

Buy
83%
Hold
17%

Profound Medical Corp Price Target

Target Price $8.61
Price $6.00
Potential
Number of Estimates 3
3 Analysts have issued a price target Profound Medical Corp 2026 . The average Profound Medical Corp target price is $8.61. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 5 Analysts recommend Profound Medical Corp to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Profound Medical Corp stock has an average upside potential 2026 of . Most analysts recommend the Profound Medical Corp stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 10.68 18.28
48.33% 71.17%
EBITDA Margin -300.84% -210.90%
21.15% 29.90%
Net Margin -260.49% -184.28%
34.35% 29.26%

5 Analysts have issued a sales forecast Profound Medical Corp 2025 . The average Profound Medical Corp sales estimate is

$18.3m
Unlock
. This is
54.14% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$20.0m 68.21%
Unlock
, the lowest is
$16.7m 40.47%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $10.7m 48.33%
2025
$18.3m 71.17%
Unlock
2026
$42.8m 134.25%
Unlock
2027
$58.3m 36.08%
Unlock
2028
$125m 113.75%
Unlock
2029
$181m 45.42%
Unlock
2030
$253m 39.77%
Unlock
2031
$322m 27.03%
Unlock
2032
$399m 24.04%
Unlock

4 Analysts have issued an Profound Medical Corp EBITDA forecast 2025. The average Profound Medical Corp EBITDA estimate is

$-38.6m
Unlock
. This is
8.42% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-35.7m 0.39%
Unlock
, the lowest is
$-44.6m 25.45%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-32.1m 16.96%
2025
$-38.6m 20.00%
Unlock
2026
$-28.5m 26.13%
Unlock
2027
$-10.7m 62.52%
Unlock
2028
$29.1m 372.21%
Unlock
2029
$59.8m 105.71%
Unlock
2030
$105m 75.78%
Unlock
2031
$138m 31.61%
Unlock
2032
$176m 26.93%
Unlock

EBITDA Margin

2024 -300.84% 21.15%
2025
-210.90% 29.90%
Unlock
2026
-66.51% 68.46%
Unlock
2027
-18.32% 72.46%
Unlock
2028
23.33% 227.35%
Unlock
2029
33.00% 41.45%
Unlock
2030
41.50% 25.76%
Unlock
2031
43.00% 3.61%
Unlock
2032
44.00% 2.33%
Unlock

5 Profound Medical Corp Analysts have issued a net profit forecast 2025. The average Profound Medical Corp net profit estimate is

$-33.7m
Unlock
. This is
5.41% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-33.5m 4.66%
Unlock
, the lowest is
$-34.2m 6.88%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-27.8m 2.63%
2025
$-33.7m 21.10%
Unlock
2026
$-26.3m 22.08%
Unlock
2027
$-34.6m 31.81%
Unlock
2028
$19.7m 157.05%
Unlock
2029
$41.6m 110.79%
Unlock
2030
$74.1m 78.06%
Unlock
2031
$97.8m 32.00%
Unlock
2032
$125m 27.31%
Unlock

Net Margin

2024 -260.49% 34.35%
2025
-184.28% 29.26%
Unlock
2026
-61.30% 66.74%
Unlock
2027
-59.37% 3.15%
Unlock
2028
15.84% 126.68%
Unlock
2029
22.97% 45.01%
Unlock
2030
29.26% 27.38%
Unlock
2031
30.41% 3.93%
Unlock
2032
31.21% 2.63%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.12 -1.12
17.04% 0.00%
P/E negative
EV/Sales 7.78

5 Analysts have issued a Profound Medical Corp forecast for earnings per share. The average Profound Medical Corp EPS is

$-1.12
Unlock
. This is
5.66% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.11 4.72%
Unlock
, the lowest is
$-1.14 7.55%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.12 17.04%
2025
$-1.12 0.00%
Unlock
2026
$-0.87 22.32%
Unlock
2027
$-1.15 32.18%
Unlock
2028
$0.66 157.39%
Unlock
2029
$1.38 109.09%
Unlock
2030
$2.47 78.99%
Unlock
2031
$3.25 31.58%
Unlock
2032
$4.14 27.38%
Unlock

P/E ratio

Current -5.66 26.69%
2025
-5.35 5.48%
Unlock
2026
-6.87 28.41%
Unlock
2027
-5.21 24.16%
Unlock
2028
9.14 275.43%
Unlock
2029
4.33 52.63%
Unlock
2030
2.43 43.88%
Unlock
2031
1.84 24.28%
Unlock
2032
1.45 21.20%
Unlock

Based on analysts' sales estimates for 2025, the Profound Medical Corp stock is valued at an EV/Sales of

and an P/S ratio of
10.05
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 11.99 52.27%
2025
7.78 35.11%
Unlock
2026
3.32 57.31%
Unlock
2027
2.44 26.52%
Unlock
2028
1.14 53.22%
Unlock
2029
0.79 31.23%
Unlock
2030
0.56 28.46%
Unlock
2031
0.44 21.27%
Unlock
2032
0.36 19.38%
Unlock

P/S ratio

Current 15.50 48.00%
2025
10.05 35.12%
Unlock
2026
4.29 57.31%
Unlock
2027
3.15 26.52%
Unlock
2028
1.48 53.22%
Unlock
2029
1.01 31.23%
Unlock
2030
0.73 28.46%
Unlock
2031
0.57 21.27%
Unlock
2032
0.46 19.39%
Unlock

Current Profound Medical Corp Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
RAYMOND JAMES LTD.
Locked
Locked
Locked Mar 05 2025
RAYMOND JAMES LTD.
Locked
Locked
Locked Dec 10 2024
LEEDE JONES GABLE
Locked
Locked
Locked Nov 03 2024
Analyst Rating Date
Locked
RAYMOND JAMES LTD.:
Locked
Locked
Mar 05 2025
Locked
RAYMOND JAMES LTD.:
Locked
Locked
Dec 10 2024
Locked
LEEDE JONES GABLE:
Locked
Locked
Nov 03 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today